Heart failure and its complications in patients with diabetes: Mounting evidence for a growing burden

Area of Science:

• Cardiology
• Endocrinology
• Pharmacology

Background:

• Heart failure (HF) is a major complication in diabetes patients, with prevalence ranging from 20% in diabetic populations to 50% in HF patients.
• Diabetes and HF share complex interrelations, including diabetes cardiomyopathy, left ventricular hypertrophy, coronary artery disease, and renal dysfunction, increasing mortality and rehospitalization.
• Current evidence suggests an elevated risk of atrial fibrillation and sudden cardiac death in individuals with diabetes.

Purpose of the Study:

• To review the intricate relationship between diabetes and heart failure.
• To evaluate current management strategies for heart failure in diabetic patients.
• To explore the role of novel glucose-lowering agents in mitigating cardiovascular risks.

Main Methods:

• Literature review of existing clinical studies and evidence.
• Analysis of the impact of diabetes on heart failure pathophysiology and outcomes.
• Evaluation of current and emerging therapeutic approaches for diabetes and heart failure co-existence.

Main Results:

• Systematic screening for HF in asymptomatic diabetes patients lacks sufficient data.
• Improved glycemic control alone shows limited impact on HF outcomes in this population.
• Specific glucose-lowering agents, particularly SGLT2 inhibitors, demonstrate significant benefits for patients with cardiovascular disease and diabetes.

Conclusions:

• Established HF management guidelines are applicable to diabetes patients.
• The choice of glucose-lowering medication is critical and should be phenotype-based.
• Future strategies must integrate glycemic control with heart failure prevention and reduction, emphasizing personalized medicine.